Table 5. The number of TILs at the invasive margin (/field).
Exploratory Group | Validation Group | |||
---|---|---|---|---|
At random | Hot spot | At random | Hot spot | |
CD4 (Median [range]) | ||||
tTILs | 4.2 (0-36.6) | 18.4 (1.2-60.4) | 2.2 (0-13.8) | 18.8 (4-51.0) |
sTILs | 4.2 (0-36.6) | 18.4 (1.2-60.4) | 2.2 (0-13.8) | 18.8 (4-51.0) |
iTILs | 0 (0-0.4) | 0 (0-0.2) | 0 (0-2.2) | 0 (0-4.4) |
CD8 (Median [range]) | ||||
tTILs | 7.6 (0.4-37.8) | 39 (9.4-114.2) | 12.5 (0.2-34.2) | 32.6 (7.0-79.6) |
sTILs | 5.0 (0-29.0) | 37.4 (3.8-114.2) | 11.6 (0.2-29.8) | 32.6 (7.0-79.6) |
iTILs | 1.6 (0-16.4) | 0 (0-16.8) | 0.2 (0-12.8) | 0 (0-4.0) |
TILs: Tumor-infiltrating lymphocytes, tTILs: total TILs (sTILs+iTILs), sTILs: TILs in tumor stroma, iTILs: TILs intra tumor cells.